Page 34 - Vitamin D and Cancer

1 Vitamin D: Synthesis and Catabolism 21

54. Cross H, Bises G, Lechner D, Manhardt T, Kallay E (2005) The Vitamin D endocrine system
of the gut - Its possible role in colorectal cancer prevention. J Steroid Biochem Mol Biol
97:121–128
55. Miller GJ, Stapleton GE, Hedlund TE, Moffat KA (1995) Vitamin D receptor expression,
24-hydroxylase activity, and inhibition of growth by 1alpha, 25-dihydroxyvitamin D3 in
seven human prostatic carcinoma cell lines. Clin Cancer Res 1(9):997–1003
56. Ly LH, Zhao XY, Holloway L, Feldman D (1999) Liarozole acts synergistically with 1alpha,
25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by block-
ing 24-hydroxylase activity. Endocrinology 140(5):2071–2076
57. Farhan H, Wahala K, Adlercreutz H, Cross HS (2002) Isoflavonoids inhibit catabolism of
vitamin D in prostate cancer cells. J Chromatogr B Anal Technol Biomed Life Sci
777(1–2):261–268
58. Farhan H, Wahala K, Cross HS (2003) Genistein inhibits vitamin D hydroxylases CYP24
and CYP27B1 expression in prostate cells. J Steroid Biochem Mol Biol 84(4):423–429
59. Calle EE, Miracle-McMahill HL, Thun MJ, Heath CW Jr (1995) Estrogen replacement
therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women.
J Natl Cancer Inst 87(7):517–523
60. DeCosse JJ, Ngoi SS, Jacobson JS, Cennerazzo WJ (1993) Gender and colorectal cancer. Eur
J Cancer Prev 2(2):105–115
61. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ (2003) Cancer statistics, 2003.
CA Cancer J Clin 53(1):5–26
62. Grodstein F, Newcomb PA, Stampfer MJ (1999) Postmenopausal hormone therapy and the
risk of colorectal cancer: a review and meta-analysis. Am J Med 106(5):574–582
63. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C et al (2004) Estrogen plus progestin and
colorectal cancer in postmenopausal women. N Engl J Med 350(10):991–1004
64. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW (2000) Selective loss of estrogen
receptor beta in malignant human colon. Cancer Res 60(2):245–248
65. Nelson LR, Bulun SE (2001) Estrogen production and action. J Am Acad Dermatol 45
(3 Suppl):S116–S124
66. Lindberg MK, Moverare S, Skrtic S et al (2003) Estrogen receptor (ER)-beta reduces
ERalpha-regulated gene transcription, supporting a “ying yang” relationship between
ERalpha and ERbeta in mice. Mol Endocrinol 17(2):203–208
67. Campbell-Thompson M, Lynch IJ, Bhardwaj B (2001) Expression of estrogen receptor (ER)
subtypes and ERbeta isoforms in colon cancer. Cancer Res 61(2):632–640
68. Buchanan JR, Santen R, Cauffman S, Cavaliere A, Greer RB, Demers LM (1986) The effect
of endogenous estrogen fluctuation on metabolism of 25-hydroxyvitamin D. Calcif Tissue
Int 39(3):139–144
69. Liel Y, Shany S, Smirnoff P, Schwartz B (1999) Estrogen increases 1, 25-dihydroxyvitamin D
receptors expression and bioresponse in the rat duodenal mucosa. Endocrinology 140(1):
280–285
70. Lechner D, Bajna E, Adlercreutz H, Cross HS (2006) Genistein and 17beta-estradiol, but not
equol, regulate vitamin D synthesis in human colon and breast cancer cells. Anticancer Res
26(4A):2597–2603
71. CH PP, Hopkins ME, Kallay E, Bises G, Dreyhaupt E, Augenlicht L, Lipkin M, Lesser M,
Livote E, Holt PR (2009) Chemoprevention of colorectal neoplasia by estrogen: potential
role of vitamin D. Cancer Prev Res 2(1):43–51
72. Horii J, Hiraoka S, Kato J et al (2008) Age-related methylation in normal colon mucosa dif-
fers between the proximal and distal colon in patients who underwent colonoscopy. Clin
Biochem 41(18):1440–1448
73. Grant WB (2002) An ecologic study of dietary and solar ultraviolet-B links to breast carci-
noma mortality rates. Cancer 94(1):272–281
74. Friedrich M, Diesing D, Cordes T et al (2006) Analysis of 25-hydroxyvitamin D3–1alpha-
hydroxylase in normal and malignant breast tissue. Anticancer Res 26(4A):2615–2620